quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:30:00·933d
PRRelease
BioPlus Acquisition Corp. logo

BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate

BIOS· BioPlus Acquisition Corp.
Finance
Original source

Companies

  • BIOS
    BioPlus Acquisition Corp.
    Finance

Related

  • PR107d
    ReAlta Life Sciences Announces Appointment of Jonathan Rigby to Board of Directors
  • 13D/G801d
    SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)
  • 13D/G804d
    SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)
  • 13D/G806d
    SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)
  • 13D/G825d
    SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)
  • SEC920d
    SEC Form 15-12G filed by BioPlus Acquisition Corp.
  • SEC930d
    SEC Form 25-NSE filed by BioPlus Acquisition Corp.
  • SEC933d
    SEC Form RW filed by BioPlus Acquisition Corp.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022